Institute for International Research

Know how to achieve

Main menu

My IBC

Login form

Sign Up

Formulation Strategies for Protein Therapeutics

Event Information

Held concurrently with IBC's BioProcess International Conference and Exposition
Formulating the Next Generation of Protein Therapeutics: Pre-Filled Syringes, High Concentration Proteins, Quality by Design and Novel Protein Structures
September 23 - 25, 2008 · Disneyland® Hotel · Anaheim, CA

Document Title

Event Overview

Event Overview

Best Rates End August 22nd
Take advantage of early discounts or use the generous team discount to allow more members of your lab group to attend at a reduced rate.

Now entering its eighth year, IBC's Formulation Strategies for Protein Therapeutics is a must-attend conference each year for formulation, delivery and analytical development scientists from biotherapeutic development organizations from around the world.

  • Understand how to optimize formulations for pre-filled syringe products from early development to commercialization with strategies from Amgen, Biogen-Idec, Human Genome Sciences, Merck, West Pharmaceutical Services and the U.S. Food and Drug Administration
  • Learn how to design quality into your protein therapeutics from the start in an important panel, "The QbD Pioneers: Perspectives from Companies that have Implemented Quality by Design Concepts in Formulation Development"
  • Overcome the challenges of formulating high concentration proteins – with case studies from Abbott Laboratories, Amgen, Genentech, Roche and Wyeth
  • Benchmark your formulation operation in a facilitated small group Best Practices Exchange for formulation scientists

The topics presented in this meeting are determined through the input of formulation scientists like you who are also trying to overcome the challenges of advanced protein therapeutics and next-generation delivery methods.

What's New for 2008...

  • New Pre-Conference Workshop: Developing Formulations for Prefilled Syringe-Based Products - From Early Development to Commercialization
  • New Scientific Issues in Lifecycle Management: How Commercial/Marketing Considerations Affect Formulation Development
  • A Keynote and Panel Discussion on the important integration of Quality by Design in formulation development
  • Two Extended Formulation Development Case Studies - showing the full progression of formulation changes from early development through to late stage clinical studies and commercialization
  • New case studies to help resolve the persistent problems of advancing formulations for high concentration proteins
  • IBC's popular Small Group Scientific Exchange Discussions, this year focusing on a personal best practices exchange for scientists from small and large research organizations

And, because Formulation Strategies is co-located with the BioProcess International™ Conference and Exhibition, you will have the opportunity to visit with more than 120 suppliers of bioprocess technology and services and network with over 1,500 industry leaders in attendance. The Disney Resort location ensures you plenty of nighttime entertainment options in walking distance and ease of transportation from major airports to the meeting.

Bottom menu

Copyright IBC Life Sciences, a part of Informa Life Sciences Group

Powered by Interactive Agency Janmedia Interactive, Inc.